Works matching AU Raskin, Joel


Results: 38
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Democratic socialism confronts psychiatry.

    Published in:
    Canadian Medical Association Journal (CMAJ), 1987, v. 136, n. 2, p. 99
    By:
    • Seeman, Mary V.;
    • Brown, Peter;
    • Cardish, Robert;
    • Chagoya, Leo;
    • Flak, Edred;
    • Greben, Stanley;
    • Leszcz, Molyn;
    • Margulies, Alfred;
    • Markson, Elliott;
    • Pakes, Ed;
    • Raskin, Joel;
    • Silver, Daniel;
    • Slonim, Rodney;
    • Rapp, Morton S.;
    • Wolkoff, Irvin I.;
    • Freebury, David R.;
    • Warme, Gordon E.
    Publication type:
    Article
    14

    Is there a 20th-century disease?

    Published in:
    Canadian Medical Association Journal (CMAJ), 1986, v. 134, n. 6, p. 578
    By:
    • Stewart, Donna Eileen;
    • Raskin, Joel;
    • Leyton, Edward;
    • Signer, Stephen F.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    On the path to 2025: understanding the Alzheimer's disease continuum.

    Published in:
    Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0283-5
    By:
    • Aisen, Paul S.;
    • Cummings, Jeffrey;
    • Jack Jr, Clifford R.;
    • Morris, John C.;
    • Sperling, Reisa;
    • Frölich, Lutz;
    • Jones, Roy W.;
    • Dowsett, Sherie A.;
    • Matthews, Brandy R.;
    • Raskin, Joel;
    • Scheltens, Philip;
    • Dubois, Bruno
    Publication type:
    Article
    25

    Drug development in Alzheimer's disease: the path to 2025.

    Published in:
    Alzheimer's Research & Therapy, 2016, v. 8, p. 1, doi. 10.1186/s13195-016-0207-9
    By:
    • Cummings, Jeffrey;
    • Aisen, Paul S.;
    • DuBois, Bruno;
    • Frölich, Lutz;
    • Jack Jr, Clifford R.;
    • Jones, Roy W.;
    • Morris, John C.;
    • Raskin, Joel;
    • Dowsett, Sherie A.;
    • Scheltens, Philip
    Publication type:
    Article
    26
    27
    28

    Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia.

    Published in:
    Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2018, v. 4, n. 1, p. 652, doi. 10.1016/j.trci.2018.10.001
    By:
    • Willis, Brian A.;
    • Sundell, Karen;
    • Lachno, D. Richard;
    • Ferguson‐Sells, Lisa R.;
    • Case, Michael G.;
    • Holdridge, Karen;
    • DeMattos, Ronald B.;
    • Raskin, Joel;
    • Siemers, Eric R.;
    • Dean, Robert A.
    Publication type:
    Article
    29

    SOLANEZUMAB CENTRAL TARGET ENGAGEMENT AND PHARMACODYNAMIC ACTIVITY IN THE EXPEDITION 3 TRIAL OF PATIENTS WITH MILD AD: COMPARISON TO EXPEDITION/EXPEDITION 2.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P254, doi. 10.1016/j.jalz.2017.06.116
    By:
    • Dean, Robert A.;
    • Sundell, Karen L.;
    • Lachno, David Richard;
    • Ferguson-Sells, Lisa R.;
    • Case, Michael G.;
    • Holdridge, Karen C.;
    • Demattos, Ronald B.;
    • Raskin, Joel;
    • Siemers, Eric R.;
    • Willis, Brian A.
    Publication type:
    Article
    30
    31

    Burden in caregivers of Alzheimer’s disease patients with and without diabetes.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P600, doi. 10.1016/j.jalz.2015.06.825
    By:
    • Lebrec, Jeremie;
    • Ascher-Svanum, Haya;
    • Chen, Yun-Fei;
    • Reed, Catherine C.;
    • Khale-Wrobleski, Kristin;
    • Hake, Ann Marie;
    • Raskin, Joel;
    • Naderali, Ebrahim;
    • Schuster, Dara P.;
    • Heine, Robert J.;
    • Kendall, David M.
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38